Skip to the page

Data / Medical devices / Germany / Angiomed GMBH & Co. Medizintechnik KG

Angiomed GMBH & Co. Medizintechnik KG: FDA-registered device maker in KARLSRUHE Baden-Wurttemberg, Germany, 5 510(k) clearances and 5 PMA approvals

Angiomed GMBH & Co. Medizintechnik KG is registered with the FDA (registration 9681442) in KARLSRUHE Baden-Wurttemberg, Germany. It lists 8 device types. The FDA files 5 510(k) clearances and 5 PMA approvals under its listings, the newest dated September 25, 2026. 1 recall event names it as the recalling firm. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
9681442
FEI number
3002806368
Address
Wachhausstrasse 6, KARLSRUHE Baden-Wurttemberg, Germany, 76227
Owner or operator
C. R. Bard, Inc. (2212754)
Roles
Complaint file establishment, Contract manufacturer, Manufacturer
First device listed
December 16, 1999
Registered through
2027
Brand names listed
Bard Fluoro-4 Silicone Ureteral Stent, Bard Lubricious-Coated Ureteral, Bardex Double Pigtail Stent, Bardex Double Pigtail Ureteral Stent with Suture, Coil Stent, Covera Vascular Covered Stent, E-LUMINEXX Biliary Stent System, E-Luminexx Vascular Stent System and more

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
August 30, 2013K130792LIFESTENT BILIARY STENT SYSTEM, LIFESTENT XL BILIARY STENT SYSTEMFGEUnknownC.R. Bard, Inc.accessdata.fda.gov
May 30, 2008K063532BARD E LUMINEXX BILIARY STENTFGEUnknownBard Peripheral Vascular, Inc.accessdata.fda.gov
March 23, 2006K060487LIFESTENT FLEXSTAR XL BILIARY STENT SYSTEMFGESubstantially EquivalentEdwards Lifesciences, LLCaccessdata.fda.gov
December 21, 2005K053404LIFESTENT FLEXSTART BILIARY STENT SYSTEMFGEUnknownEdwards Lifesciences, LLCaccessdata.fda.gov
May 6, 2003K031186LUMINEXX ENDOSCOPIC BILIARY STENTFGEUnknownC.R. Bard, Inc.accessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
September 25, 2026P250050Liverty™ TIPS Stent GraftMIR1October 23, 2026accessdata.fda.gov
March 13, 2019P180037Venovo Venous Stent SystemQAN14June 10, 2026accessdata.fda.gov
July 30, 2018P170042Covera™ Vascular Covered StentPFV14June 10, 2026accessdata.fda.gov
February 13, 2009P070014LIFESTENT FLEXSTAR & FLEXSTAR XL VASCULAR STENT SYSTEMNIP66June 10, 2026accessdata.fda.gov
December 4, 2008P080007BARD E-LUMINEXX VASCULAR STENTNIO24May 26, 2022accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
July 28, 200532853Not yet classifiedTerminatedBard Luminexx Endoscopic Biliary Stent and Delivery System, 7.5 FR, 8 mm x 60 mm Catalog Number: LXB08060Biliary Stents may malfunction and cause failure to expand, fracture, incomplete deployment, inaccurate positioning, migration, or lumen perforation.accessdata.fda.gov

Compare with other makers

Updated October 23, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.